Fungal infections increased substantially in the last years, becoming a relevant public health problem.
Introduction
Fungal infections increased substantially in the last years, becoming a relevant public health problem.
Many of these infections account for high rates of morbidity and mortality. Candidiasis, an opportunistic fungal infection is caused by fungi belonging to the Candida genus [1] . Although the antifungal agents used in clinical treatments of mycosis have sometimes proved efficient, they are restricted to few targets in fungal cells with high toxicity to humans [2] . In addition, the problem increases with the emergence of resistant clinical isolates [3, 4] , which makes the search for new antifungal therapies extremely relevant.
Since the discovery of spongouridine, molecular model of the first antiviral used as a therapeutic resource for Acquired Immunodeficiency Syndrome (AIDS), the biodiversity of the marine ecosystem has been considered a rich source of bioactive metabolites due to the complexity and originality of its structures [5] . In this scenario, peptides from marine organisms have been shown to have antiviral, antiinflammatory, antimalarial, anticancer, antimicrobial and antifungal properties [6] [7] [8] .
Arenicins are antimicrobial peptides isolated from the marine lugworm Arenicola marina with 21 amino acid residues in a β-hairpin structure (Figure 1 ).
In vitro and in vivo studies have shown that arenicins exhibit a very potent bactericidal and antifungal effect against multi-resistant gram-negative bacteria and Candida albicans, respectively [9] . In bacterial, Arenicin interacts with membrane lipids promoting membrane permeabilization and detachment besides affecting cytoplasm metabolism [10] . However, the interaction of arenicin with important antifungal targets from Candida albicans is unknown.
Dihydrofolate reductase (DHFR) catalyzes the reduction of dihydrofolic acid to tetrahydrofolic acid [11] .
The enzyme acts on the synthesis of purines, thymidylic acid, amino acids and the regulation of tetrahydrofolate levels in the cell, participating in proliferation and growth [12] . The protein exo-b-(1,3)-glucanase (EBG) takes part in cell expansion and differentiation through cell wall remodeling. EBG is also secreted during pathogenesis [13] . Finally, CYP51 (sterol 14α-demethylase) is a major drug target in the cytochrome P450 superfamily. This enzyme is related to ergosterol and membranes metabolism [14] . All the 
Material and Methods
All the 3-D structures used in the analysis are available in the PDB (protein databank; https:// www.rcsb.org/). KBDOCK server were used in order to assess protein domains and possible interaction between protein domains [16] . The protein docking was performed by ClusPro [17] . We used PyMol [18, 19] .
Results and Discussion
The Arenicin Properties are Defined by its Amino Acid Composition
Arginine and valine account for 54% of the amino acid residues present in the arenicin structure 
Arenicin is Surround by Hot Spots Residues in a Cleft of CYP51
CYP51 is required for ergosterol biosynthesis [36] . It has been extensively investigated as the main target for azole antimicrobial drugs [37] [38] [39] .
We found 11 hot spot residues on the C. albicans CYP51 interface of interaction with the peptide arenicin ( Figure   7 ). The necessity of finding new target to fungal diseases is real, since azoles, although having the ability to inhibit CYP51, are toxic to mammals cells and lead to severe side effects in patients [40] [41] [42] [43] . The marine peptide arenicin is held near the active site of the enzyme by the hydrophobicity in that area. Inhibition of CYP51 leads to disruption of the membrane and cell death. The marine peptide fits in a cleft of the protein, at the entrance of the active site, and is surrounded by hot spot residues, interacting with them via hydrogen bonds.
Concluding Remarks
The number of deaths of immunocompromised patients caused by opportunistic fungi, including C. albicans, has increased significantly [44] . The Green amino acids are hot spots on EBG and the yellow amino acid residue was classified as a hot spot and belongs to the active site of EBG, an important residue for inhibiting assays. 
